Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Noradrenaline in Cardiogenic Shock From Acute Myocardial Infarction
NCT05168462Phase 4Recruiting
- Sponsor
- University of Amsterdam
- Start
- Oct 2022
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norepinephrine in cardiogenic shock, sponsored by University of Amsterdam. Started Oct 2022; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on NCT05168462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168462.